[Effects of yarn polysaccharide on antioxidant capacity of mice with Alzheimer disease]

Related Experiment Video

Updated: Apr 11, 2026

Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
08:27

Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein

Published on: July 29, 2018

12.8K

Ling Zhong, Zhen-fu Wang

    Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology
    |May 29, 2015
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis06:17

    A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

    Published on: May 22, 2018

    12.8K
    Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons06:23

    Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

    Published on: October 30, 2018

    8.6K

    Related Concept Videos

    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    1.2K